nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—Rash vesicular—Pazopanib—kidney cancer	0.0365	0.0643	CcSEcCtD
Adapalene—Oral herpes—Temsirolimus—kidney cancer	0.0285	0.0502	CcSEcCtD
Adapalene—Oral herpes—Everolimus—kidney cancer	0.0212	0.0374	CcSEcCtD
Adapalene—Oral herpes—Sunitinib—kidney cancer	0.0177	0.0312	CcSEcCtD
Adapalene—Keratoconjunctivitis—Capecitabine—kidney cancer	0.0126	0.0222	CcSEcCtD
Adapalene—Eyelid oedema—Pazopanib—kidney cancer	0.0126	0.0221	CcSEcCtD
Adapalene—Vesiculobullous rash—Temsirolimus—kidney cancer	0.012	0.0211	CcSEcCtD
Adapalene—Pain of skin—Paclitaxel—kidney cancer	0.0119	0.021	CcSEcCtD
Adapalene—Herpes labialis—Doxorubicin—kidney cancer	0.0102	0.018	CcSEcCtD
Adapalene—Eyelid oedema—Everolimus—kidney cancer	0.00991	0.0174	CcSEcCtD
Adapalene—Oral herpes—Capecitabine—kidney cancer	0.00978	0.0172	CcSEcCtD
Adapalene—Feeling hot—Temsirolimus—kidney cancer	0.00857	0.0151	CcSEcCtD
Adapalene—Rash pustular—Temsirolimus—kidney cancer	0.00843	0.0148	CcSEcCtD
Adapalene—Eyelid oedema—Sunitinib—kidney cancer	0.00828	0.0146	CcSEcCtD
Adapalene—Keratitis—Erlotinib—kidney cancer	0.00744	0.0131	CcSEcCtD
Adapalene—Herpes simplex—Temsirolimus—kidney cancer	0.0073	0.0128	CcSEcCtD
Adapalene—Skin discolouration—Pazopanib—kidney cancer	0.00701	0.0123	CcSEcCtD
Adapalene—Oral herpes—Doxorubicin—kidney cancer	0.0063	0.0111	CcSEcCtD
Adapalene—Rash pustular—Erlotinib—kidney cancer	0.00605	0.0107	CcSEcCtD
Adapalene—Skin exfoliation—Pazopanib—kidney cancer	0.00605	0.0106	CcSEcCtD
Adapalene—Eczema—Temsirolimus—kidney cancer	0.00543	0.00956	CcSEcCtD
Adapalene—Dermatitis exfoliative—Temsirolimus—kidney cancer	0.00517	0.0091	CcSEcCtD
Adapalene—Dermatitis bullous—Temsirolimus—kidney cancer	0.00511	0.00899	CcSEcCtD
Adapalene—Skin exfoliation—Everolimus—kidney cancer	0.00478	0.0084	CcSEcCtD
Adapalene—Face oedema—Temsirolimus—kidney cancer	0.00471	0.00829	CcSEcCtD
Adapalene—Skin discolouration—Sunitinib—kidney cancer	0.00463	0.00814	CcSEcCtD
Adapalene—Skin exfoliation—Erlotinib—kidney cancer	0.00461	0.00811	CcSEcCtD
Adapalene—Dermatitis atopic—Gemcitabine—kidney cancer	0.00453	0.00797	CcSEcCtD
Adapalene—Dry skin—Temsirolimus—kidney cancer	0.00447	0.00787	CcSEcCtD
Adapalene—Face oedema—Pazopanib—kidney cancer	0.00444	0.00781	CcSEcCtD
Adapalene—Keratitis—Paclitaxel—kidney cancer	0.00433	0.00762	CcSEcCtD
Adapalene—Dry skin—Pazopanib—kidney cancer	0.00422	0.00742	CcSEcCtD
Adapalene—Redness—Paclitaxel—kidney cancer	0.00416	0.00732	CcSEcCtD
Adapalene—Skin exfoliation—Sorafenib—kidney cancer	0.00415	0.0073	CcSEcCtD
Adapalene—Skin exfoliation—Sunitinib—kidney cancer	0.00399	0.00702	CcSEcCtD
Adapalene—Dermatitis exfoliative—Everolimus—kidney cancer	0.00385	0.00677	CcSEcCtD
Adapalene—Dermatitis atopic—Paclitaxel—kidney cancer	0.00379	0.00667	CcSEcCtD
Adapalene—Dermatitis bullous—Erlotinib—kidney cancer	0.00367	0.00645	CcSEcCtD
Adapalene—Conjunctivitis—Temsirolimus—kidney cancer	0.00366	0.00644	CcSEcCtD
Adapalene—Photosensitivity reaction—Pazopanib—kidney cancer	0.00363	0.00638	CcSEcCtD
Adapalene—Keratitis—Capecitabine—kidney cancer	0.00355	0.00625	CcSEcCtD
Adapalene—Eczema—Sorafenib—kidney cancer	0.00351	0.00617	CcSEcCtD
Adapalene—Eczema—Sunitinib—kidney cancer	0.00338	0.00594	CcSEcCtD
Adapalene—Dermatitis exfoliative—Sorafenib—kidney cancer	0.00334	0.00588	CcSEcCtD
Adapalene—Dry skin—Everolimus—kidney cancer	0.00333	0.00586	CcSEcCtD
Adapalene—Dry skin—Erlotinib—kidney cancer	0.00321	0.00565	CcSEcCtD
Adapalene—Skin exfoliation—Gemcitabine—kidney cancer	0.0032	0.00563	CcSEcCtD
Adapalene—Dermatitis bullous—Sunitinib—kidney cancer	0.00317	0.00558	CcSEcCtD
Adapalene—Skin discolouration—Paclitaxel—kidney cancer	0.00311	0.00547	CcSEcCtD
Adapalene—Herpes simplex—Paclitaxel—kidney cancer	0.00305	0.00536	CcSEcCtD
Adapalene—Erythema—Temsirolimus—kidney cancer	0.00294	0.00517	CcSEcCtD
Adapalene—Face oedema—Sunitinib—kidney cancer	0.00293	0.00515	CcSEcCtD
Adapalene—Dry skin—Sorafenib—kidney cancer	0.00289	0.00508	CcSEcCtD
Adapalene—Dry skin—Sunitinib—kidney cancer	0.00278	0.00489	CcSEcCtD
Adapalene—Erythema—Pazopanib—kidney cancer	0.00277	0.00487	CcSEcCtD
Adapalene—Conjunctivitis—Everolimus—kidney cancer	0.00272	0.00479	CcSEcCtD
Adapalene—Angioedema—Temsirolimus—kidney cancer	0.00269	0.00473	CcSEcCtD
Adapalene—Skin exfoliation—Paclitaxel—kidney cancer	0.00268	0.00472	CcSEcCtD
Adapalene—Vesiculobullous rash—Doxorubicin—kidney cancer	0.00265	0.00466	CcSEcCtD
Adapalene—Conjunctivitis—Erlotinib—kidney cancer	0.00262	0.00462	CcSEcCtD
Adapalene—Skin discolouration—Capecitabine—kidney cancer	0.00255	0.00449	CcSEcCtD
Adapalene—Convulsion—Temsirolimus—kidney cancer	0.00255	0.00448	CcSEcCtD
Adapalene—Dermatitis bullous—Gemcitabine—kidney cancer	0.00255	0.00448	CcSEcCtD
Adapalene—Hepatitis—Everolimus—kidney cancer	0.00251	0.00442	CcSEcCtD
Adapalene—Herpes simplex—Capecitabine—kidney cancer	0.0025	0.0044	CcSEcCtD
Adapalene—Hepatitis—Erlotinib—kidney cancer	0.00242	0.00427	CcSEcCtD
Adapalene—Optic neuritis—Doxorubicin—kidney cancer	0.00241	0.00425	CcSEcCtD
Adapalene—Face oedema—Gemcitabine—kidney cancer	0.00235	0.00413	CcSEcCtD
Adapalene—Keratitis—Doxorubicin—kidney cancer	0.00229	0.00403	CcSEcCtD
Adapalene—Eye pain—Paclitaxel—kidney cancer	0.00226	0.00397	CcSEcCtD
Adapalene—Redness—Doxorubicin—kidney cancer	0.0022	0.00387	CcSEcCtD
Adapalene—Skin exfoliation—Capecitabine—kidney cancer	0.0022	0.00387	CcSEcCtD
Adapalene—Erythema—Everolimus—kidney cancer	0.00219	0.00385	CcSEcCtD
Adapalene—Seborrhoeic dermatitis—Doxorubicin—kidney cancer	0.00218	0.00383	CcSEcCtD
Adapalene—Dermatitis exfoliative—Paclitaxel—kidney cancer	0.00216	0.0038	CcSEcCtD
Adapalene—Burning sensation—Doxorubicin—kidney cancer	0.00214	0.00376	CcSEcCtD
Adapalene—Erythema—Erlotinib—kidney cancer	0.00211	0.00371	CcSEcCtD
Adapalene—Hepatitis—Sunitinib—kidney cancer	0.0021	0.00369	CcSEcCtD
Adapalene—Pain—Temsirolimus—kidney cancer	0.00205	0.00361	CcSEcCtD
Adapalene—Photosensitivity reaction—Vincristine—kidney cancer	0.00202	0.00356	CcSEcCtD
Adapalene—Dermatitis atopic—Doxorubicin—kidney cancer	0.00201	0.00353	CcSEcCtD
Adapalene—Angioedema—Everolimus—kidney cancer	0.002	0.00352	CcSEcCtD
Adapalene—Hepatitis—Dactinomycin—kidney cancer	0.00199	0.0035	CcSEcCtD
Adapalene—Pain—Pazopanib—kidney cancer	0.00193	0.0034	CcSEcCtD
Adapalene—Convulsion—Vinblastine—kidney cancer	0.0019	0.00335	CcSEcCtD
Adapalene—Erythema—Sorafenib—kidney cancer	0.0019	0.00334	CcSEcCtD
Adapalene—Convulsion—Everolimus—kidney cancer	0.00189	0.00333	CcSEcCtD
Adapalene—Feeling hot—Doxorubicin—kidney cancer	0.00189	0.00333	CcSEcCtD
Adapalene—Dry skin—Paclitaxel—kidney cancer	0.00187	0.00329	CcSEcCtD
Adapalene—Rash pustular—Doxorubicin—kidney cancer	0.00186	0.00328	CcSEcCtD
Adapalene—Eye pain—Capecitabine—kidney cancer	0.00185	0.00326	CcSEcCtD
Adapalene—Stinging—Doxorubicin—kidney cancer	0.00183	0.00323	CcSEcCtD
Adapalene—Erythema—Sunitinib—kidney cancer	0.00183	0.00321	CcSEcCtD
Adapalene—Dermatitis exfoliative—Capecitabine—kidney cancer	0.00177	0.00312	CcSEcCtD
Adapalene—Hypersensitivity—Temsirolimus—kidney cancer	0.00177	0.00311	CcSEcCtD
Adapalene—Dermatitis bullous—Capecitabine—kidney cancer	0.00175	0.00308	CcSEcCtD
Adapalene—Angioedema—Sorafenib—kidney cancer	0.00173	0.00305	CcSEcCtD
Adapalene—Erythema—Dactinomycin—kidney cancer	0.00173	0.00304	CcSEcCtD
Adapalene—Pruritus—Temsirolimus—kidney cancer	0.0017	0.00299	CcSEcCtD
Adapalene—Angioedema—Sunitinib—kidney cancer	0.00167	0.00294	CcSEcCtD
Adapalene—Skin discolouration—Doxorubicin—kidney cancer	0.00164	0.00289	CcSEcCtD
Adapalene—Face oedema—Capecitabine—kidney cancer	0.00161	0.00284	CcSEcCtD
Adapalene—Herpes simplex—Doxorubicin—kidney cancer	0.00161	0.00284	CcSEcCtD
Adapalene—Photosensitivity reaction—Paclitaxel—kidney cancer	0.00161	0.00283	CcSEcCtD
Adapalene—Pruritus—Pazopanib—kidney cancer	0.0016	0.00281	CcSEcCtD
Adapalene—Convulsion—Sunitinib—kidney cancer	0.00158	0.00279	CcSEcCtD
Adapalene—Dry skin—Capecitabine—kidney cancer	0.00153	0.0027	CcSEcCtD
Adapalene—Pain—Vinblastine—kidney cancer	0.00153	0.0027	CcSEcCtD
Adapalene—Conjunctivitis—Paclitaxel—kidney cancer	0.00153	0.00269	CcSEcCtD
Adapalene—Pain—Everolimus—kidney cancer	0.00153	0.00269	CcSEcCtD
Adapalene—Rash—Temsirolimus—kidney cancer	0.00151	0.00266	CcSEcCtD
Adapalene—Dermatitis—Temsirolimus—kidney cancer	0.00151	0.00266	CcSEcCtD
Adapalene—Pain—Erlotinib—kidney cancer	0.00147	0.00259	CcSEcCtD
Adapalene—Dermatitis contact—Doxorubicin—kidney cancer	0.00147	0.00258	CcSEcCtD
Adapalene—Erythema—Gemcitabine—kidney cancer	0.00147	0.00258	CcSEcCtD
Adapalene—Rash—Pazopanib—kidney cancer	0.00143	0.00251	CcSEcCtD
Adapalene—Dermatitis—Pazopanib—kidney cancer	0.00142	0.00251	CcSEcCtD
Adapalene—Skin exfoliation—Doxorubicin—kidney cancer	0.00142	0.00249	CcSEcCtD
Adapalene—Convulsion—Vincristine—kidney cancer	0.00134	0.00236	CcSEcCtD
Adapalene—Pain—Sorafenib—kidney cancer	0.00132	0.00233	CcSEcCtD
Adapalene—Hypersensitivity—Vinblastine—kidney cancer	0.00132	0.00232	CcSEcCtD
Adapalene—Photosensitivity reaction—Capecitabine—kidney cancer	0.00132	0.00232	CcSEcCtD
Adapalene—Hypersensitivity—Everolimus—kidney cancer	0.00132	0.00231	CcSEcCtD
Adapalene—Pain—Sunitinib—kidney cancer	0.00127	0.00224	CcSEcCtD
Adapalene—Pruritus—Everolimus—kidney cancer	0.00126	0.00222	CcSEcCtD
Adapalene—Conjunctivitis—Capecitabine—kidney cancer	0.00125	0.0022	CcSEcCtD
Adapalene—Urticaria—Sorafenib—kidney cancer	0.00123	0.00217	CcSEcCtD
Adapalene—Erythema—Paclitaxel—kidney cancer	0.00123	0.00216	CcSEcCtD
Adapalene—Pruritus—Erlotinib—kidney cancer	0.00122	0.00214	CcSEcCtD
Adapalene—Pain—Dactinomycin—kidney cancer	0.00121	0.00212	CcSEcCtD
Adapalene—Eczema—Doxorubicin—kidney cancer	0.0012	0.00211	CcSEcCtD
Adapalene—Eye pain—Doxorubicin—kidney cancer	0.00119	0.0021	CcSEcCtD
Adapalene—Hepatitis—Capecitabine—kidney cancer	0.00116	0.00204	CcSEcCtD
Adapalene—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.00114	0.00201	CcSEcCtD
Adapalene—Hypersensitivity—Sorafenib—kidney cancer	0.00114	0.00201	CcSEcCtD
Adapalene—Dermatitis bullous—Doxorubicin—kidney cancer	0.00113	0.00198	CcSEcCtD
Adapalene—Rash—Everolimus—kidney cancer	0.00113	0.00198	CcSEcCtD
Adapalene—Dermatitis—Everolimus—kidney cancer	0.00112	0.00198	CcSEcCtD
Adapalene—Angioedema—Paclitaxel—kidney cancer	0.00112	0.00197	CcSEcCtD
Adapalene—Hypersensitivity—Sunitinib—kidney cancer	0.0011	0.00193	CcSEcCtD
Adapalene—Pruritus—Sorafenib—kidney cancer	0.0011	0.00193	CcSEcCtD
Adapalene—Rash—Erlotinib—kidney cancer	0.00109	0.00191	CcSEcCtD
Adapalene—Dermatitis—Erlotinib—kidney cancer	0.00108	0.00191	CcSEcCtD
Adapalene—Pain—Vincristine—kidney cancer	0.00108	0.0019	CcSEcCtD
Adapalene—Convulsion—Paclitaxel—kidney cancer	0.00106	0.00187	CcSEcCtD
Adapalene—Pruritus—Sunitinib—kidney cancer	0.00105	0.00186	CcSEcCtD
Adapalene—Face oedema—Doxorubicin—kidney cancer	0.00104	0.00183	CcSEcCtD
Adapalene—Hypersensitivity—Dactinomycin—kidney cancer	0.00104	0.00183	CcSEcCtD
Adapalene—Pain—Gemcitabine—kidney cancer	0.00102	0.0018	CcSEcCtD
Adapalene—Erythema—Capecitabine—kidney cancer	0.00101	0.00177	CcSEcCtD
Adapalene—Dry skin—Doxorubicin—kidney cancer	0.000988	0.00174	CcSEcCtD
Adapalene—Rash—Sorafenib—kidney cancer	0.000977	0.00172	CcSEcCtD
Adapalene—Dermatitis—Sorafenib—kidney cancer	0.000976	0.00172	CcSEcCtD
Adapalene—Rash—Sunitinib—kidney cancer	0.00094	0.00165	CcSEcCtD
Adapalene—Dermatitis—Sunitinib—kidney cancer	0.000939	0.00165	CcSEcCtD
Adapalene—Hypersensitivity—Vincristine—kidney cancer	0.000929	0.00163	CcSEcCtD
Adapalene—RARA—Gene Expression—EIF5B—kidney cancer	0.000919	0.00213	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—EIF5B—kidney cancer	0.000919	0.00213	CbGpPWpGaD
Adapalene—RXRA—Retinoic acid receptors-mediated signaling—MAPK3—kidney cancer	0.000892	0.00207	CbGpPWpGaD
Adapalene—Rash—Dactinomycin—kidney cancer	0.00089	0.00157	CcSEcCtD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—ERBB2—kidney cancer	0.000885	0.00205	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000872	0.00202	CbGpPWpGaD
Adapalene—RXRA—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000862	0.002	CbGpPWpGaD
Adapalene—Pain—Paclitaxel—kidney cancer	0.000856	0.00151	CcSEcCtD
Adapalene—RXRA—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000855	0.00198	CbGpPWpGaD
Adapalene—Photosensitivity reaction—Doxorubicin—kidney cancer	0.00085	0.0015	CcSEcCtD
Adapalene—RXRA—Retinoic acid receptors-mediated signaling—MAPK1—kidney cancer	0.000849	0.00197	CbGpPWpGaD
Adapalene—Pruritus—Gemcitabine—kidney cancer	0.000846	0.00149	CcSEcCtD
Adapalene—RXRA—Biological oxidations—GSTT1—kidney cancer	0.000825	0.00191	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—SLC5A5—kidney cancer	0.000809	0.00187	CbGpPWpGaD
Adapalene—Conjunctivitis—Doxorubicin—kidney cancer	0.000807	0.00142	CcSEcCtD
Adapalene—Urticaria—Paclitaxel—kidney cancer	0.000796	0.0014	CcSEcCtD
Adapalene—Rash—Vincristine—kidney cancer	0.000795	0.0014	CcSEcCtD
Adapalene—Dermatitis—Vincristine—kidney cancer	0.000794	0.0014	CcSEcCtD
Adapalene—RXRA—NRF2 pathway—SLC2A1—kidney cancer	0.000781	0.00181	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—PTGS1—kidney cancer	0.000773	0.00179	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—SPTBN4—kidney cancer	0.000763	0.00177	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—L1CAM—kidney cancer	0.000763	0.00177	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000758	0.00176	CbGpPWpGaD
Adapalene—Rash—Gemcitabine—kidney cancer	0.000754	0.00133	CcSEcCtD
Adapalene—Dermatitis—Gemcitabine—kidney cancer	0.000754	0.00133	CcSEcCtD
Adapalene—Hepatitis—Doxorubicin—kidney cancer	0.000746	0.00131	CcSEcCtD
Adapalene—Hypersensitivity—Paclitaxel—kidney cancer	0.000738	0.0013	CcSEcCtD
Adapalene—RXRA—NRF2 pathway—EGR1—kidney cancer	0.000726	0.00168	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000718	0.00166	CbGpPWpGaD
Adapalene—RXRA—PPARA activates gene expression—CYP1A1—kidney cancer	0.000712	0.00165	CbGpPWpGaD
Adapalene—Pruritus—Paclitaxel—kidney cancer	0.000709	0.00125	CcSEcCtD
Adapalene—Pain—Capecitabine—kidney cancer	0.000703	0.00124	CcSEcCtD
Adapalene—RXRA—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000699	0.00162	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000697	0.00161	CbGpPWpGaD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—kidney cancer	0.000697	0.00161	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—JUNB—kidney cancer	0.000693	0.00161	CbGpPWpGaD
Adapalene—RARG—Gene Expression—EEF2—kidney cancer	0.000689	0.0016	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000688	0.00159	CbGpPWpGaD
Adapalene—RXRA—Regulation of Androgen receptor activity—JUN—kidney cancer	0.000685	0.00159	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000682	0.00158	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—CTNNB1—kidney cancer	0.000677	0.00157	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CER1—kidney cancer	0.000667	0.00155	CbGpPWpGaD
Adapalene—RARG—Gene Expression—TET2—kidney cancer	0.00066	0.00153	CbGpPWpGaD
Adapalene—Urticaria—Capecitabine—kidney cancer	0.000653	0.00115	CcSEcCtD
Adapalene—RXRA—NRF2 pathway—GSTP1—kidney cancer	0.000652	0.00151	CbGpPWpGaD
Adapalene—Erythema—Doxorubicin—kidney cancer	0.000649	0.00114	CcSEcCtD
Adapalene—RXRA—Vitamin A and Carotenoid Metabolism—MAPK1—kidney cancer	0.000637	0.00147	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—CTNNB1—kidney cancer	0.000636	0.00147	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—JUNB—kidney cancer	0.000634	0.00147	CbGpPWpGaD
Adapalene—Rash—Paclitaxel—kidney cancer	0.000631	0.00111	CcSEcCtD
Adapalene—Dermatitis—Paclitaxel—kidney cancer	0.000631	0.00111	CcSEcCtD
Adapalene—RXRG—Gene Expression—EEF2—kidney cancer	0.00063	0.00146	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000626	0.00145	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000626	0.00145	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—JUNB—kidney cancer	0.000622	0.00144	CbGpPWpGaD
Adapalene—RARB—Gene Expression—EEF2—kidney cancer	0.000618	0.00143	CbGpPWpGaD
Adapalene—Hypersensitivity—Capecitabine—kidney cancer	0.000606	0.00107	CcSEcCtD
Adapalene—RARG—Gene Expression—TCEB2—kidney cancer	0.000604	0.0014	CbGpPWpGaD
Adapalene—RARG—Gene Expression—TCEB1—kidney cancer	0.000604	0.0014	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—TET2—kidney cancer	0.000604	0.0014	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—HNF1A—kidney cancer	0.000603	0.0014	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—EPAS1—kidney cancer	0.000603	0.0014	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—GSTM1—kidney cancer	0.000599	0.00139	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—JUNB—kidney cancer	0.000596	0.00138	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—JUNB—kidney cancer	0.000596	0.00138	CbGpPWpGaD
Adapalene—RARA—Gene Expression—EEF2—kidney cancer	0.000592	0.00137	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—EEF2—kidney cancer	0.000592	0.00137	CbGpPWpGaD
Adapalene—RARB—Gene Expression—TET2—kidney cancer	0.000592	0.00137	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000585	0.00136	CbGpPWpGaD
Adapalene—Pruritus—Capecitabine—kidney cancer	0.000582	0.00102	CcSEcCtD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—RELA—kidney cancer	0.00058	0.00134	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—GSTP1—kidney cancer	0.000572	0.00132	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—TET2—kidney cancer	0.000568	0.00132	CbGpPWpGaD
Adapalene—RARA—Gene Expression—TET2—kidney cancer	0.000568	0.00132	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000565	0.00131	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000563	0.00131	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—HARS—kidney cancer	0.000563	0.0013	CbGpPWpGaD
Adapalene—Convulsion—Doxorubicin—kidney cancer	0.000562	0.00099	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000557	0.00129	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—HIF1A—kidney cancer	0.000554	0.00128	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—TCEB2—kidney cancer	0.000552	0.00128	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—TCEB1—kidney cancer	0.000552	0.00128	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000545	0.00126	CbGpPWpGaD
Adapalene—RARB—Gene Expression—TCEB1—kidney cancer	0.000542	0.00125	CbGpPWpGaD
Adapalene—RARB—Gene Expression—TCEB2—kidney cancer	0.000542	0.00125	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.00054	0.00125	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000534	0.00124	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—kidney cancer	0.000533	0.00123	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—GSTM1—kidney cancer	0.000525	0.00122	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000523	0.00121	CbGpPWpGaD
Adapalene—RARA—Gene Expression—TCEB2—kidney cancer	0.000519	0.0012	CbGpPWpGaD
Adapalene—RARA—Gene Expression—TCEB1—kidney cancer	0.000519	0.0012	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—TCEB2—kidney cancer	0.000519	0.0012	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—TCEB1—kidney cancer	0.000519	0.0012	CbGpPWpGaD
Adapalene—Rash—Capecitabine—kidney cancer	0.000518	0.000912	CcSEcCtD
Adapalene—Dermatitis—Capecitabine—kidney cancer	0.000518	0.000911	CcSEcCtD
Adapalene—RXRG—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000516	0.0012	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000516	0.0012	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000514	0.00119	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000509	0.00118	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000506	0.00117	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—CYP1A1—kidney cancer	0.000498	0.00115	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000498	0.00115	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000495	0.00115	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000492	0.00114	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—HNF1B—kidney cancer	0.000492	0.00114	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000491	0.00114	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000491	0.00114	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000491	0.00114	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000491	0.00114	CbGpPWpGaD
Adapalene—RARG—Gene Expression—RPL14—kidney cancer	0.000491	0.00114	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000488	0.00113	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000485	0.00112	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000485	0.00112	CbGpPWpGaD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—kidney cancer	0.00048	0.00111	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—EIF5B—kidney cancer	0.000479	0.00111	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000475	0.0011	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000472	0.00109	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000471	0.00109	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000468	0.00108	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000456	0.00106	CbGpPWpGaD
Adapalene—Pain—Doxorubicin—kidney cancer	0.000453	0.000797	CcSEcCtD
Adapalene—RXRG—Gene Expression—RPL14—kidney cancer	0.000449	0.00104	CbGpPWpGaD
Adapalene—RARB—Gene Expression—RPL14—kidney cancer	0.00044	0.00102	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ACY1—kidney cancer	0.000438	0.00101	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000429	0.000994	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—RPL14—kidney cancer	0.000422	0.000978	CbGpPWpGaD
Adapalene—RARA—Gene Expression—RPL14—kidney cancer	0.000422	0.000978	CbGpPWpGaD
Adapalene—Urticaria—Doxorubicin—kidney cancer	0.000421	0.000741	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000412	0.000953	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000406	0.000941	CbGpPWpGaD
Adapalene—RARG—Gene Expression—HSPB1—kidney cancer	0.0004	0.000927	CbGpPWpGaD
Adapalene—RARG—Gene Expression—EIF4EBP1—kidney cancer	0.0004	0.000927	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000395	0.000915	CbGpPWpGaD
Adapalene—Hypersensitivity—Doxorubicin—kidney cancer	0.00039	0.000687	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000389	0.000902	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000386	0.000895	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000379	0.000877	CbGpPWpGaD
Adapalene—Pruritus—Doxorubicin—kidney cancer	0.000375	0.00066	CcSEcCtD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000374	0.000865	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PDHB—kidney cancer	0.000372	0.000863	CbGpPWpGaD
Adapalene—RARG—Gene Expression—PSMD7—kidney cancer	0.000372	0.000862	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—POMC—kidney cancer	0.000371	0.00086	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.00037	0.000858	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—EIF4EBP1—kidney cancer	0.000366	0.000848	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—HSPB1—kidney cancer	0.000366	0.000848	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.000365	0.000845	CbGpPWpGaD
Adapalene—RARB—Gene Expression—EIF4EBP1—kidney cancer	0.000359	0.000831	CbGpPWpGaD
Adapalene—RARB—Gene Expression—HSPB1—kidney cancer	0.000359	0.000831	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000359	0.000831	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CTNNA1—kidney cancer	0.000353	0.000817	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CCBL1—kidney cancer	0.00035	0.000811	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.00035	0.000811	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—HSPB1—kidney cancer	0.000344	0.000797	CbGpPWpGaD
Adapalene—RARA—Gene Expression—EIF4EBP1—kidney cancer	0.000344	0.000797	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—EIF4EBP1—kidney cancer	0.000344	0.000797	CbGpPWpGaD
Adapalene—RARA—Gene Expression—HSPB1—kidney cancer	0.000344	0.000797	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—PSMD7—kidney cancer	0.00034	0.000788	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—PAX6—kidney cancer	0.000337	0.000782	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	0.000335	0.000777	CbGpPWpGaD
Adapalene—Rash—Doxorubicin—kidney cancer	0.000334	0.000588	CcSEcCtD
Adapalene—RARG—Gene Expression—JUNB—kidney cancer	0.000334	0.000773	CbGpPWpGaD
Adapalene—Dermatitis—Doxorubicin—kidney cancer	0.000334	0.000587	CcSEcCtD
Adapalene—RARB—Gene Expression—PSMD7—kidney cancer	0.000334	0.000773	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—CTNNB1—kidney cancer	0.000332	0.000768	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.000324	0.000751	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	0.000321	0.000745	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—PSMD7—kidney cancer	0.00032	0.000741	CbGpPWpGaD
Adapalene—RARA—Gene Expression—PSMD7—kidney cancer	0.00032	0.000741	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000317	0.000734	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.000311	0.00072	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—JUNB—kidney cancer	0.000311	0.00072	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—EEF2—kidney cancer	0.000309	0.000715	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—JUNB—kidney cancer	0.000305	0.000707	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PPAT—kidney cancer	0.000304	0.000703	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GLIPR1—kidney cancer	0.000304	0.000703	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.0003	0.000694	CbGpPWpGaD
Adapalene—RARB—Gene Expression—JUNB—kidney cancer	0.000299	0.000694	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000297	0.000687	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—TET2—kidney cancer	0.000296	0.000685	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—PAK1—kidney cancer	0.000293	0.000678	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—JUNB—kidney cancer	0.000287	0.000665	CbGpPWpGaD
Adapalene—RARA—Gene Expression—JUNB—kidney cancer	0.000287	0.000665	CbGpPWpGaD
Adapalene—RXRA—Metabolism—FH—kidney cancer	0.000282	0.000654	CbGpPWpGaD
Adapalene—RXRA—Metabolism—APRT—kidney cancer	0.000282	0.000654	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000282	0.000652	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000279	0.000645	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000276	0.000639	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000272	0.000631	CbGpPWpGaD
Adapalene—RARG—Gene Expression—CDKN2B—kidney cancer	0.000272	0.00063	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—TCEB2—kidney cancer	0.000271	0.000627	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—TCEB1—kidney cancer	0.000271	0.000627	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GPC3—kidney cancer	0.000265	0.000615	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000259	0.0006	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CA2—kidney cancer	0.000258	0.000598	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000258	0.000597	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000253	0.000586	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ALAD—kidney cancer	0.000252	0.000583	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.00025	0.00058	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—CDKN2B—kidney cancer	0.000249	0.000576	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000246	0.00057	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ST3GAL2—kidney cancer	0.000246	0.000569	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000246	0.000569	CbGpPWpGaD
Adapalene—RARB—Gene Expression—CDKN2B—kidney cancer	0.000244	0.000565	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000244	0.000564	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ALDH1A1—kidney cancer	0.00024	0.000556	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000238	0.00055	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—CDKN2B—kidney cancer	0.000234	0.000541	CbGpPWpGaD
Adapalene—RARA—Gene Expression—CDKN2B—kidney cancer	0.000234	0.000541	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SLC5A3—kidney cancer	0.00023	0.000533	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PGK1—kidney cancer	0.00023	0.000533	CbGpPWpGaD
Adapalene—RXRA—Metabolism—LDHB—kidney cancer	0.000226	0.000523	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—RPL14—kidney cancer	0.00022	0.000509	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—MYC—kidney cancer	0.000219	0.000507	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000215	0.000497	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000203	0.00047	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—MYC—kidney cancer	0.0002	0.000463	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000198	0.000458	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000197	0.000457	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—MYC—kidney cancer	0.000196	0.000455	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CA9—kidney cancer	0.000196	0.000453	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000193	0.000447	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000191	0.000443	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—MYC—kidney cancer	0.000188	0.000436	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—MYC—kidney cancer	0.000188	0.000436	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.000182	0.000422	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—KDR—kidney cancer	0.000182	0.000422	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—EIF4EBP1—kidney cancer	0.000179	0.000415	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—HSPB1—kidney cancer	0.000179	0.000415	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MET—kidney cancer	0.000178	0.000413	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	0.000168	0.000388	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—PSMD7—kidney cancer	0.000167	0.000386	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CRABP1—kidney cancer	0.000166	0.000385	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.000162	0.000375	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ITPR2—kidney cancer	0.000155	0.000358	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—JUNB—kidney cancer	0.00015	0.000347	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000143	0.00033	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTT1—kidney cancer	0.000141	0.000327	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ACHE—kidney cancer	0.000141	0.000327	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SCARB1—kidney cancer	0.000134	0.000309	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PTGS1—kidney cancer	0.000132	0.000306	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—RAF1—kidney cancer	0.000132	0.000305	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—RELA—kidney cancer	0.000131	0.000304	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—ERBB2—kidney cancer	0.00013	0.000302	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PSMD7—kidney cancer	0.00013	0.0003	CbGpPWpGaD
Adapalene—RXRA—Metabolism—BCHE—kidney cancer	0.000123	0.000285	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—CDKN2B—kidney cancer	0.000122	0.000282	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SLC5A5—kidney cancer	0.000121	0.000281	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SLC2A1—kidney cancer	0.000117	0.000272	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CTNNB1—kidney cancer	0.000114	0.000264	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000114	0.000263	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000112	0.000259	CbGpPWpGaD
Adapalene—RARG—Gene Expression—MAPK3—kidney cancer	0.000108	0.000251	CbGpPWpGaD
Adapalene—RARG—Gene Expression—MYC—kidney cancer	0.000105	0.000244	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—VEGFA—kidney cancer	0.0001	0.000232	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.92e-05	0.00023	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—MAPK3—kidney cancer	9.9e-05	0.000229	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—MYC—kidney cancer	9.8e-05	0.000227	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTP1—kidney cancer	9.78e-05	0.000226	CbGpPWpGaD
Adapalene—RARB—Gene Expression—MAPK3—kidney cancer	9.71e-05	0.000225	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—MYC—kidney cancer	9.63e-05	0.000223	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MAPK3—kidney cancer	9.49e-05	0.00022	CbGpPWpGaD
Adapalene—RARB—Gene Expression—MYC—kidney cancer	9.45e-05	0.000219	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—MAPK3—kidney cancer	9.31e-05	0.000216	CbGpPWpGaD
Adapalene—RARA—Gene Expression—MAPK3—kidney cancer	9.31e-05	0.000216	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ABCB1—kidney cancer	9.25e-05	0.000214	CbGpPWpGaD
Adapalene—RARA—Gene Expression—MYC—kidney cancer	9.06e-05	0.00021	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—MYC—kidney cancer	9.06e-05	0.00021	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MAPK1—kidney cancer	9.03e-05	0.000209	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTM1—kidney cancer	8.98e-05	0.000208	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—KRAS—kidney cancer	8.53e-05	0.000198	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP1A1—kidney cancer	8.52e-05	0.000197	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7e-05	0.000162	CbGpPWpGaD
Adapalene—RXRA—Metabolism—POMC—kidney cancer	6.35e-05	0.000147	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PTGS2—kidney cancer	5.06e-05	0.000117	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—MAPK3—kidney cancer	4.85e-05	0.000112	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—MYC—kidney cancer	4.72e-05	0.000109	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PTEN—kidney cancer	4.42e-05	0.000102	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PIK3CA—kidney cancer	3.12e-05	7.22e-05	CbGpPWpGaD
